Skip to main content

Canadian drug companies join forces to produce monkeypox vaccine

Share

Montreal-based biopharmaceutical company PnuVax and Ontario-based drug manufacturer Biolyse Pharma announced Wednesday that they have signed an agreement to mass produce a monkeypox vaccine.

The two companies say they have the capabilities to produce millions of doses nationwide.

The undertaking could add up to 50 employees per company.

Monkeypox is a highly contagious disease that can cause painful lesions.

About 1,000 cases have been reported in Canada to date.

-- This report by The Canadian Press was first published in French on Aug. 10, 2022. 

CTVNews.ca Top Stories

opinion

opinion Harry and Meghan's Nigerian adventure: Traditional attire to warm welcomes

For her latest column on CTVNews.ca, royal commentator Afua Hagan writes about Prince Harry and Meghan Markle's recent visit to Nigeria, calling it a 'deeply meaningful campaign' that was about aligning their ongoing efforts to foster mental-health awareness and promoting the Invictus Games.

Stay Connected